Malnutrition continues to be highly prevalent in hospitalized and critically ill patients and is associated with significant morbidity and mortality. Additionally, survivors of critical illness have an increased risk for sarcopenia, which leads to weakness and physical debilitation that can persist for years. Nutrition risk assessment tools have been developed and validated in critically ill patients but have limitations. Variables such as body weight, body mass index, weight change, or percentage of food intake can be difficult to obtain in critically ill patients and may be misleading given changes in body composition, such as an increase in body water. Assessment of body composition through new techniques provides a unique opportunity to counter some of these limitations and develop improved methods of nutrition risk assessment based on objective data. The present manuscript provides a review of the most commonly available clinical technology for assessment of body composition (bioimpedance, computed tomography, and ultrasound), including data from trials in critically ill patients highlighting the benefits and weaknesses of each modality. (Nutr Clin Pract. 2019;34:48-58) 
Introduction
Malnutrition is estimated to occur in 40%-50% of critically ill patients 1, 2 and is associated with impaired immune function, prolonged ventilator dependence, increased infectious complications, and increased overall morbidity and mortality. 2 Additionally, survivors of critical illness are at increased risk to acquire significant sarcopenia, or loss of muscle mass and strength, during and after their sentinel intensive care unit (ICU) admission. Sarcopenia leads to muscle weakness, physical debilitation, and impairments in quality of life that can persist for years. [3] [4] [5] [6] Identifying patients at risk for developing malnutrition and sarcopenia is paramount for optimization of post-ICU recovery and preventing associated sequelae.
Nutrition risk is the risk of acquiring complications because of undernutrition or malnutrition. Tools have been developed and validated to identify nutrition risk in critically ill patients. One such tool is the Nutrition Risk Score-2002, which includes 4 components associated with malnutrition: body mass index (BMI) <20 kg/m 2 , loss of weight in the previous 3 months, decreased nutrition intake, and severe illness. 7 If any factor is positive, a subsequent assessment based on nutrition status and severity of disease is performed. The Nutrition Risk in Critically Ill (NUTRIC) scoring system has been specifically developed for the ICU population and uses 5 variables to calculate a risk score: age, Acute Physiology and Chronic Health Assessment (APACHE) II, Sequential Organ Failure Assessment, number of comorbidities, and days from hospital to ICU admission. 8 Interleukin-6 was initially utilized in the score, but because of lack of test availability at most institutions, a modified NUTRIC score has been validated to include 4 components. 9 A modified NUTRIC score of 5 or greater indicates nutrition risk.
Although these scores have been validated in a diverse population, they currently rely on variables such as body weight, BMI, or prehospitalization weight change. Limitations of BMI include inability to distinguish various obesity phenotypes, such as sarcopenic obesity. In the elderly and obese, these variables may not accurately capture the clinically pertinent changes in body composition, such as the gain of fluid or fat mass and/or loss of lean body mass (LBM) in a weight-stable patient. 10 Additionally, obtaining an accurate weight history from a critically ill patient may be difficult. Laboratory measurements, such as albumin and other serum proteins, can be affected by the acutephase response and change in intravascular volume, making them inaccurate biomarkers of nutrition status in critically ill patients. 11, 12 Body composition may provide a more accurate assessment of sarcopenia.
There are numerous methods to evaluate body composition, including computed tomography (CT), ultrasound, bioimpedance, dual-energy x-ray absorptiometry (DXA), and magnetic resonance imaging (MRI). These modalities have been used in clinical research to measure lean and adipose tissue stores but have not been readily available in hospitalized patients because of limited availability of equipment and logistics involved in obtaining the scan. 13 The present manuscript aims to provide a narrative review of currently available and emerging technologies for evaluating body composition in the critically ill patient.
Body Composition and Clinical Outcomes in Critical Illness
Body composition refers to the compartmentalization and quantification of various components, such as fat mass, LBM, and bone mass or skeleton (Figure 1 ). LBM typically refers to the combination of total body protein, carbohydrates, nonfat lipids, soft tissue mineral, and body water.
14 Fat-free mass (FFM) includes the LBM and bone mineral component. Fat mass encompasses adipose tissue consisting of adipocytes, collagenous and elastic fibers, fibroblasts, and capillaries. In clinical practice, BMI is calculated from height and weight and is the most commonly used metric to separate underweight from overweight and obese. BMI is readily available in most electronic medical records. Despite its widespread use, BMI fails to account for many variables that are essential for risk stratification, including location of adipose tissue stores (upper body vs lower body or visceral vs subcutaneous), amount of LBM vs fat mass, and fluid status. Measurement of waist circumference (WC) may offer some additional details about body composition, allowing for further delineation of upper body vs lower body stores. WC can be especially useful in stratifying high-risk individuals with BMI in the overweight range or class I obesity and is a key part of the metabolic syndrome definition.
Despite being readily available, BMI and WC do not estimate LBM and skeletal muscle mass, which have been shown to be key predictors of outcomes in critically ill patients. [15] [16] [17] Sarcopenia can be difficult to identify in individuals with obesity when simply considering BMI or body weight (Figure 2 ). In fact, Moisey et al identified that 71% of elderly patients with traumatic injuries were sarcopenic, and only 9% of the sarcopenic patients were underweight, whereas 47% were considered overweight or obese per BMI classification. 15 The implications of this finding are tremendous since, when compared with those with normal muscle mass, sarcopenic critically ill patients tend to have higher mortality, more ventilator days, and longer ICU and hospital stays. 15, 16 Critically ill patients may acquire sarcopenia from a combination of muscle breakdown and decreased protein synthesis. 3 Some studies have estimated that critically ill patients can lose 17%-30% of their muscle mass within the first 10 days of ICU admission. 18 Patients with multiple organ failure lose more muscle mass compared with those with single organ failure. 5 The combination of preexisting and acquired sarcopenia can result in significantly worse physical function and longterm disability up to 5 years after ICU stay. 4 Clearly, current anthropometric parameters, such as body weight or BMI, are not sensitive enough to identify the presence of sarcopenia in critically ill patients, especially in the setting of obesity.
Different Modalities for Body Composition Assessment

Bioimpedance Techniques
Bioimpedance analysis (BIA) utilizes a low-amplitude alternating electrical current at either 1 (single-frequency) or multiple (multifrequency) radiofrequencies to characterize the conductive and nonconductive fluid and tissue components of the body (Table 1 and Figure 3 ). 19 The current review will focus on key concepts of BIA and clinical findings in critically ill patients, as comprehensive discussion detailing the techniques and assumptions underlying BIA has been provided in several excellent reviews. [19] [20] [21] Fat, bone, and air-filled spaces poorly conduct electrical currents, whereas water and electrolyte-rich tissues, such as muscle and blood, are excellent electrical current conductors. 19, 20 Sensing electrodes are able to detect the impedance or frequency-dependent opposition to the flow of electric current as it passes through the body. Impedance is composed of 2 frequency-dependent parameters: resistance or opposition to the flow of current and reactance, which is the delay in conduction caused by cell membranes, tissue interfaces, and nonionic substances. 19 In critically ill patients, resistance can be associated with the degree of edema and reactance to the degree of severity of illness. 22 The property of capacitance, or tendency for the cell membranes to store a portion of the current for a short time, is utilized to calculate both extracellular water (ECW) and total body water (TBW). At low frequencies, the high cell membrane capacitance does not allow electrical current conduction, allowing for quantification of ECW. High frequencies surpass the cell membrane capacitance, allowing full conduction and calculation of TBW. Intracellular water (ICW) is then typically calculated by subtracting ECW from TBW. Based on the assumption that cells are 70% water, the body cell mass can then also be generated from ICW. 19, 23 Three different technologies of bioimpedance are currently available: single-frequency BIA (SF-BIA), multifrequency BIA (MF-BIA), and bioimpedance spectroscopy (BIS). SF-BIA utilizes a single frequency (50 kHz) to estimate whole-body composition, with the electrodes typically placed at the wrist and ankles ( Figure 3 ). Given that only 1 frequency is used, the various components of body composition are then derived from regression equations. As an example, TBW can be calculated based on a regression equation developed and validated with dilution methods using deuterium or Oxygen-18 serving as the reference. 24, 25 FFM can then be calculated using the assumption that it is hydrated at approximately 73%. 25, 26 Finally, fat mass can be calculated by subtracting FFM from the total body weight. Often, the regression equations are derived and validated from healthy normal-weight individuals in the ambulatory setting, providing inaccurate results in scenarios where hydration of FFM can be significantly higher, such as in fluid overload states or in individuals with obesity. 19, [26] [27] [28] [29] Unfortunately, SF-BIA considers the entire body as a single uniform cylinder and assumes the ICW-to-ECW ratio remains constant and that the bioelectrical current is conducted uniformly (Figure 3 ). These assumptions are often not true in critically ill patients, in whom electrolyte shifts and changes in distribution of fluid between intracellular and extracellular compartments can perturb the results. 19, 30, 31 Similarly, in states where ECW expansion has occurred (heart failure, renal failure, or critical illness), FFM can be overestimated. 32 Because of these inherent drawbacks, there is movement to utilize the raw data generated from SF-BIA to predict nutrition status without relying on regression equations. 19 More specifically, phase angle, which is a derived measure obtained from direct measurement of resistance and reactance, can be interpreted as an indicator of membrane integrity and water distribution between intracellular and extracellular spaces. 33 Phase angle has been noted to be a prognostic indicator, with studies revealing a positive association with survival in patients with HIV, malignancy, hemodialysis, and critical illness (discussed further below). [34] [35] [36] MF-BIA, as opposed to SF-BIA, uses 2 or more frequencies starting at a low frequency (5 kHz) and then proceeding through multiple higher frequencies (50 kHz, 100 kHz, 200 kHz, 500 kHz, etc.). One advantage of the use of multiple frequencies is to allow for better determination of fluid within body compartments, as lower and higher frequencies allow quantification of EBW and TBW, respectively. 20 Additionally, many MF-BIA devices available also use a multisegmental approach, which divides the body into 5 distinct cylinders (2 upper extremities, 2 lower extremities, and the trunk) and thus theoretically provides more accurate estimates (Figure 3 ). This approach tries to correct for limitations inherent to the single segment whole-body BIA, such as the fact that the trunk contributes very little to the whole-body resistance (10%) but contains a large proportion (50%) of conductor volume. 37 The BIS approach takes this one step forward and typically measures impedance at a minimum of 50 frequencies ranging from <5 kHz to as high as 1200 kHz. This provides a theoretical advantage over SF-BIA and MF-BIA in which BIS does not rely on prediction equations but rather uses nonlinear least squares curve fitting techniques using all of the impedance data to generate whole-body volume and masses. The use of very high frequencies also allows for more complete quantification of TBW. Unfortunately, BIS still has to rely on mixture equations, such as those first developed by Xitron Technologies (San Diego, CA) in 1990, which assumed that many of the constants are appropriate across the range of body composition. 19 Although a correction introduced by Moissl et al did reduce the error in ICW introduced by increasing adiposity in these equations, variability at the individual level is still observed when measures are compared with reference methods.
38,39
BIA-ICU Outcomes
Despite the individual-level variability, bioimpedance offers some significant benefits over CT or DXA in allowing repeated measurements to be performed at the bedside. Given that most critically ill patients have either fluid overload or significant compartment flux, SF-BIA has proven to be quite inaccurate, yielding significant overestimations of change in TBW (median = 12%; range = 0%-46%). 40 In their study, Bracco et al also noted that in post-cardiac surgery patients, fluid balance was overestimated by SF-BIA (108% at 50 kHz and 121% at 100 kHz) 41 when compared with measured fluid balance. Given that MF-BIA and BIS use both lower and higher frequencies, they theoretically should more reliably capture TBW and fluid within the various body compartments, such as ECW and ICW. Unfortunately, clinical trials have yielded mixed results, probably because of differing populations studied and the predictive algorithm utilized. Using one of the earliest BIS devices and algorithms (Xitron 4000B), Plank et al found that BIS underestimated ECW (compared with bromide as gold standard) in 37 patients admitted to the ICU because of major trauma or sepsis at both day 0 and day 10 but provided a similar mean 10-day loss in ECW. 42 In a study comparing SF-BIA to BIS in 8 men 6 hours postelective coronary artery bypass graft, BIS using the Xitron 4000B device and accompanying software was able to more accurately capture ECW compared with SF-BIA but yielded less accuracy with TBW measures. 43 Raw BIA data have been used to follow trends and predict clinical outcomes, especially mortality. Shime et al compared the preoperative and postoperative bioimpedance measurements in the lower extremities using SF-BIA (50 kHz) in pediatric patients admitted to the ICU after congenital heart surgery and noted that those with a bioimpedance (BI) ratio (postoperative BI/preoperative BI) of <0.8 1 day after surgery had a higher mortality (25%) and longer ICU stay compared with those with a ratio of ࣙ1. 44 Azevedo et al utilized SF-BIA on all pediatric patients within 48 hours of admission to the ICU and on every 7 days afterwards and noted that an increase in both resistance and reactance at 50 kHz was found in survivors. 22 Although they had a small number of nonsurvivors, a trend toward a decline in both parameters was observed in nonsurvivors. Máttar et al compared raw parameters from SF-BIA in septic and nonseptic patients with healthy controls in an adult Brazilian population and found that capacitance and phase angle at 50 kHz declined in proportion to severity of illness. 36 Dabrowski et al, using TBW trends gathered with BIS (Xitron Hydra 4200 and accompanying software), ECW, and ECW/ICW in 37 patients undergoing continuous veno-venous hemofiltration, found a sustained increase in these parameters among nonsurvivors. 38, 45 Based on the current available data, bioimpedance measurements in critically ill patients remain promising. Raw parameters from SF-BIA, such as capacitance and phase angle, have been linked to severity of illness. However, bioimpedance technology continues to have difficulty with the diversity of illness and fluid overloaded state found in most critically ill patients. Additional research is still necessary to further define equations that will generate more accurate measurements in critically ill patients and allow for clinical management based on those values.
CT
CT offers another avenue to measure body composition and improves upon the amount of detail provided within each body compartment ( Table 1) . As an example, in the abdominal compartment, DXA can provide overall quantification of body compartments, such as bone, lean tissue mass, and fat mass (Table 1) ; however, CT imaging can further define these compartments with abdominal adipose tissue being delineated into visceral, intramuscular, and subcutaneous adipose tissue (Figure 2) . 46 FFM can also be divided into specific skeletal muscle groups and visceral organs. In research trials, multislice whole-body imaging with either MRI or CT has been considered a reference standard for measuring total body adipose tissue and skeletal muscle.
A number of teams have validated the use of a singleslice (typically mid-third lumbar [mid-L3] vertebral slice) regional analysis to predict whole-body fat and FFM in a large spectrum of ages and ethnicities. [46] [47] [48] Additionally, researchers have also used a single-slice CT estimate of total psoas muscle cross-sectional area (CSA) to identify sarcopenia. 14 This differentiation of tissues can be performed because of the fact that each tissue has a specific range of radio density, which characterizes the amount of x-ray radiation absorbed by each element in tissue. 49, 50 This radio density is then given a numerical value called the Hounsfield Unit (HU) with each tissue having the following typical ranges: −29 to 150 for skeletal muscle (includes psoas, erector spinae, quadrates lumborum, transverse abdominus, external and internal obliques, and rectus abdominus) and −150 to −50 for visceral, subcutaneous, and intramuscular adipose tissue. 51, 52 The CSA (cm 2 ) of the tissue identified is then obtained by using software to sum tissue pixels and multiply by body surface area.
The relationship of L3 total CSA to whole-body fat mass, FFM, and skeletal muscle has been well correlated with whole-body DXA measures in previous trials. 46 As an example of clinical use in critically ill patients, Weijs et al retrospectively studied the use of L3 CT imaging in patients admitted to the ICU with length of stay of at least 4 days and requiring mechanical ventilation, with 240 patients having appropriate scans for analysis. 53 They noted that 63% of patients had low muscle area, and hospital mortality was significantly higher in those with sarcopenia compared with normal muscle area in females (47.5% vs 20.0%) and in males (32.3% vs 7.5%). In regression analysis, muscle area, gender, and APACHE II scores were independent predictors of hospital mortality. 53 Single-slice CT also has the theoretical ability to identify abnormal muscle or muscle with excess accumulation of triglycerides. Pathological accumulation of fat in the skeletal muscle (myosteatosis) is associated with obesityrelated comorbidities, such as diabetes and reduced muscle activity. 51, 54 Generally, skeletal muscle is further quantified into abnormal or normal muscle, with the lower limit of attenuation for normal muscle being 30 HU, which is 2 standard deviations below the mean attenuation value across all pixels of muscle in young healthy vounteers. 51, 52 Patel et al recently piloted the partitioning of healthy from unhealthy psoas muscle CSA (using HU), which may be more relevant in risk-stratifying sarcopenic obesity. 50 Two experienced radiologists traced the L3 right and left psoas muscles, and HU cutoffs were utilized to identify abnormal muscle (−29 to 29 HU), fat (−190 to 29 HU), and normal muscle (>29 HU). Individuals with obesity had a greater difference between normal and abnormal muscle compared with individuals without obesity, and there was a negative correlation between the proportions of normal muscle to BMI. Additionally, there was poor correlation between total psoas CSA and BMI, indicating that the proportion of normal to abnormal muscle may be a better predictor of outcomes in individuals with obesity. Given that this was a pilot study, additional validation, especially in critically ill patients, is necessary.
CT scans have a number of limitations. In addition to high radiation dose, obtaining CT scans requires patient transport out of the ICU, which can pose a logistical challenge in a sedated, mechanically ventilated patient requiring multiple support apparatuses. On the contrary, it is not uncommon for critically ill patients to have undergone abdominal CT imaging at least once, if not multiple times, allowing for retrospective image analysis. The CT scans of the abdomen can be reanalyzed at the midpoint of the L3 vertebral region to estimate muscle area, which serves as a surrogate for whole-body muscle area in healthy populations but is now well established in critically ill patients. However, depending on the resolution of the scanner, the thickness of the CT scan slice can be 4-5 times that of the average height of L3 vertebrae. 55 Because of this technicality, multiple L3 slices can exist, and care must be taken to ensure consistent image acquisition for analysis. Additionally, patient positioning can dramatically impact the CSA, leading to differing results, especially in prospective trials. Ideally, CT images should be captured with the same scanner and operator with protocolized positioning of the patient. However, this is often not practical in the clinical setting.
CT-ICU Outcomes
CT scan of L3 intervertebral image has been utilized to assess clinical outcomes in critically ill patients. Braunschweig et al screened 301 patients who were admitted to the ICU over a 12-month period and noted that 35 of them had at least 2 CT scans that included L3 imaging. 13 The CT scans were an average of 10 days apart and revealed that there was an average skeletal muscle decline of 0.49% per day over this time. Regression analysis revealed that percent of energy needs received was the only significant predictor of skeletal muscle decline. Despite the patients only receiving 41% of their estimated energy needs, they noted a decline of only 1% in visceral fat mass and 4% of intermuscular fat depot.
Docimo et al performed a retrospective analysis of trauma patients with preoperative CT scan from 2008 to 2015 and were able to analyze 57 patients. 56 They focused on adiposity instead of muscle mass and noted that there was no correlation between visceral to subcutaneous adipose tissue ratio and length of stay or postoperative complications. Moisey et al analyzed L3 CT scan images of 153 injured elderly patients aged ࣙ65 years admitted to a Level 1 trauma center for skeletal muscle and adipose tissue CSAs. 15 They noted that based on CT image, 71% of patients were sarcopenic at the time of ICU admission, with 38% of the sarcopenic group being overweight and 9% being obese. Overall mortality was 27%, with the sarcopenic group having twice the mortality as the nonsarcopenic group (32% vs 14%). Sarcopenic patients also had decreased ventilatorfree days, decreased ICU-free days, and less probability of being discharged home. In a follow-up study, Moisey et al evaluated the estimation of LBM by either predictive equations or by the use of L3 skeletal muscle CSA in a critically ill population. 57 CT scans from elderly patients in the study referenced above, as well as a randomized control trial of adult patients with ࣙ2 organ failures upon admission to the ICU were used as reference, and the equation of LBM (kg) = 0.30 × [skeletal muscle at L3 (cm 2 )] + 6.06 was compared with 4 well-known predictive equations. They noted that LBM was overestimated by 13%-18% in critically ill patients by the predictive equations compared with CT, which was not surprising given that the equations were derived from healthy and chronically ill patients.
Of the body composition techniques discussed in the current manuscript, CT scans of the abdomen can be quite useful clinically. Many critically ill patients have scans that have already been performed, allowing the clinician to review the L3 image and grossly assess for the amount of muscle, as well as visceral and subcutaneous adipose tissue. This information can be quite useful in further differentiating 2 patients of equal weight, especially in the setting of fluid overload. Additionally, software is available, such as OsiriX (Pixmeo, Switzerland) and SliceOmatic (TomoVision, Montreal, Canada), that allows for further assessment of the image. However, care must be taken to ensure that the correct image is analyzed because of the high resolution of many scanners capturing multiple images within L3 vertebra. Each software can also provide differing results for the same image, so care must be taken to ensure standardization. 58 Because of these drawbacks, at this point, additional large clinical trials are necessary prior to widespread adoption of this technology in critically ill patients, and we would recommend that most readers work with radiology colleagues at their institute prior to implementing in their practice.
Ultrasound
Ultrasound generates an image based on the amplitude of reflected high-frequency sound waves and the speed at which they travel throughout the body. 55 Because of significant advantages over CT scanning, including no radiation exposure and ability to be performed at the bedside, there is growing interest in using ultrasound to assess skeletal muscle to determine the presence of sarcopenia and/or malnutrition (Table 1) . 55 In their validation study, Paris et al utilized the quadriceps muscle group, an accessible landmark muscle group with well-defined fascial borders, to predict whole-body muscle mass in healthy populations and immobile patients. 16 They chose to use quadriceps thickness over CSA for ease of identification and measurement. Additionally, underlying tissues were maximally compressed (applied as much pressure as allowed by the patient), using the ultrasound transducer to account for edema. They also evaluated for intrarater and interrater reliability and noted that intraclass correlation coefficient ranged between 0.93 and 1.0, with a mean of 0.98 in 119 paired ultrasound assessments. However, when compared with L3 CT scan CSA, quadriceps muscle thickness only moderately correlated with abdominal skeletal muscle (r = 0.45, P < 0.001). The correlation increased to 0.61 in a regression model that added age, sex, BMI, Charlson's comorbidity index, and admission type. A recent publication evaluated the reliability of a 4-site protocol using minimal vs maximal compression in healthy volunteers and noted that maximal compression produced significantly worse intrarater reliability. 60 Although this validation study was not performed in critically ill patients, their findings can be extrapolated to indicate that a minimal compression technique may be better.
Quality of muscle, as opposed to quantity, is being studied using echogenicity, or the ability of muscle to reflect ultrasound waves. 18, 55, 61, 62 Using this technique, a 2 × 2-cm region of interest is identified and undergoes computerassisted quantitative gray-scale analysis assessing intensity level. 18 Healthy tissue contains minimal fat or fibrous tissue and thus leads to little sound reflection. Increased muscle echogenicity has been shown to be associated with intramuscular adipose and fibrous tissue, reflecting disease state, whereas lower estimates of echogenicity are associated with higher muscle density and quality. [61] [62] [63] In noncritically ill patients, increased echogenicity has also been shown to correlate with decreased muscle strength and function. 64 It is important to note that external factures, such as the angle at which the probe is applied to the tissue surface and the orientation of the scanned image (longitudinal or transverse), can also significantly change the echogenicity measures. 61 
Ultrasound-ICU Outcomes
Although skeletal muscle ultrasonography moderately correlates with other body composition measurement techniques, it has been used effectively to capture the loss of muscle mass with prolonged critical illness. Gruther et al captured quadriceps muscle thickness in 17 patients within 24 hours of presenting to ICU and 28 days later (longitudinal group) and in 101 patients at variable time after admission to the ICU (cross-sectional group). 65 They noted a logarithmic loss of muscle mass that was quite rapid in the first 2-3 weeks and much higher than bedrest experiments conducted in healthy subjects. These findings are in agreement with previous reports of substantial nitrogen losses during ICU stay using more sophisticated techniques (eg, neutron activation analysis). 66 Quadriceps thickness showed a significantly negative correlation with length of stay in the ICU in both groups. Reid et al assessed the mean muscle thickness from 3 measurements at the mid-upper arm, forearm, and thigh, respectively, and noted a decrease in muscle thickness of 1.6% per day in 50 critically ill patients with multiorgan failure. 67 Using indirect calorimetry to determine energy needs, they also found no correlation between positive or negative energy balance and loss of muscle thickness. In fact, patients in positive energy balance lost 1.1% muscle thickness per day, whereas those in negative energy balance lost 1.25% per day. Similarly, Parry et al also confirmed rapid muscle deterioration by obtaining serial quadriceps ultrasound images over 10 days in 22 critically ill and ventilated adults. 18 They noted a 30% reduction in both muscle thickness and CSA within 10 days of admission. Additionally, overall muscle echogenicity scores increased, suggesting deterioration in muscle quality. Muscle strength and function at time of ICU discharge correlated strongly with muscle thickness and moderately with echogenicity.
Puthucheary et al has also published 2 trials utilizing ultrasonography in critically ill patients. By performing serial ultrasounds of the rectus femoris muscle, they noted an overall 12.5% decline in CSA from day 1 to day 7 and further decline by 17.7% at day 10. 3 This decline was much greater in those with multiorgan failure compared with those with single-organ failure. Further support for the ultrasound findings was provided through infusions of radiolabeled leucine and phenylalanine, which revealed that catabolism of muscle protein continued to exceed synthesis at both day 1 and day 7 of critical illness. In a follow-up study, rectus femoris echogenicity was evaluated. 62 They noted that, at baseline, patients with history of chronic disease had higher echogenicity compared with those without it. Additionally, patients who developed myofibril necrosis on biopsy tended to have greater change in echogenicity, indicating that change in echogenicity could serve as a marker of myofibril necrosis.
Ultrasound measurements have demonstrated utility in measuring decline in muscle mass in critically ill patients, providing opportunity for providers to act in an effort to prevent ICU-related debility. However, there is currently no consensus for using ultrasonography to predict FFM or whole-body muscle mass, with researchers using variable protocols that differ in choice of muscle group, extent of compression of underlying tissue with the ultrasound transducer, and use of muscle thickness or CSA. Additional large clinical trials will be necessary to develop protocols that standardize the ultrasound techniques, such as muscle compression and transducer probe angle, prior to widespread use.
Conclusions
Given the detrimental health effects of malnutrition and sarcopenia, since the 1990's we have seen the development and implementation of a wide range of screening tools to assist in identifying the malnourished patient. The ready availability of tools to measure body composition at the bedside presents a paradigm shift in our ability to diagnose and treat patients who are at significant nutrition risk. Although these tools have been available for a number of years, their utilization and validation in critically ill patients remains limited, and additional research is needed in this population to account for some unique body composition changes, such as increases in TBW. Additionally, larger multicenter trials are needed to further develop standardized protocols and predictive equations that allow for minimization of measurement errors and improved measurement of body composition. These studies leading to consensus and the development of standardized protocols will allow for improved correlation with clinical outcomes and more widespread implementation of body composition techniques.
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